Clearview Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Clearview Wealth Advisors LLC

$139 Million
Q2 2025

A detailed history of Clearview Wealth Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clearview Wealth Advisors LLC holds 5,783 shares of BMY stock, worth $270,991. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,783

Previous 5,820 0.64%

Holding current value

$270,991

Previous $354,000 24.58%

% of portfolio

0.19%

Previous 0.27%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	SELL	$44.12 - $59.6 $1,632 - $2,205	-37 Reduced 0.64%	5,783 $267,000
Q1 2025 Apr 22, 2025	SELL	$53.9 - $63.11 $10,294 - $12,054	-191 Reduced 3.18%	5,820 $354,000
Q4 2024 Jan 24, 2025	SELL	$51.92 - $59.94 $3,530 - $4,075	-68 Reduced 1.12%	6,011 $339,000
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $9,359 - $12,213	-236 Reduced 3.74%	6,079 $314,000
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $12,477 - $16,426	-310 Reduced 4.68%	6,315 $262,000
Q1 2024 Apr 09, 2024	SELL	$47.98 - $54.4 $10,171 - $11,532	-212 Reduced 3.1%	6,625 $359,000
Q4 2023 Jan 12, 2024	SELL	$48.48 - $57.85 $4,702 - $5,611	-97 Reduced 1.4%	6,837 $350,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $36,586 - $40,909	-632 Reduced 8.35%	6,934 $402,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $693,037 - $769,509	-10,878 Reduced 58.98%	7,566 $483,000
Q1 2023 Apr 12, 2023	BUY	$65.71 - $74.53 $505,507 - $573,359	7,693 Added 71.56%	18,444 $1.28 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $3,492 - $4,135	-51 Reduced 0.47%	10,751 $773,000
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $0 - $461	6 Added 0.06%	10,802 $768,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $27,886 - $30,712	384 Added 3.69%	10,796 $831,000
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $2,028 - $2,432	33 Added 0.32%	10,412 $760,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $5,899 - $6,877	-110 Reduced 1.05%	10,379 $647,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $25,265 - $29,595	427 Added 4.24%	10,489 $621,000
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $22,597 - $24,608	365 Added 3.76%	10,062 $672,000
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $3,263 - $3,670	-55 Reduced 0.56%	9,697 $612,000
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $563,080 - $638,073	9,752 New	9,752 $605,000

Others Institutions Holding BMY

# of Institutions

2,736

Shares Held

1.59B

Call Options Held

26M

Put Options Held

24.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearview Wealth Advisors LLC with notifications on news.

Account

Clearview Wealth Advisors LLC Bristol Myers Squibb CO Transaction History